Skip to main content
. 2022 Jan 26;7(1):e00674-21. doi: 10.1128/msphere.00674-21

TABLE 2.

Number (and %) of participants tested with a detectable antigen-specific IgA ASC response, 7 days after the second and third vaccine dose

Post 2nd injection
Post 3rd injection
PorA FetA OMV PorA FetA OMV
25 μg NT NT NT 3/20 (15%) 0/20 (0%) 15/20 (75%)
50 μg 8/23 (35%) 2/23 (9%) 17/23 (74%) 6/19 (32%) 0/19 (0%) 16/19 (84%)